The Prognostic Utility of <i>KRAS</i> Mutations in Tissue and Circulating Tumour DNA in Colorectal Cancer Patients

The Prognostic Utility of <i>KRAS</i> Mutations in Tissue and Circulating Tumour DNA in Colorectal Cancer Patients

This study aims to investigate the long-term prognostic utility of circulating tumour DNA (ctDNA) <i>KRAS</i> mutations in colorectal cancer (CRC) patients and compare this with <i>KRAS</i> mutations in matched tissue samples. Tumour tissue (<i>n</i> = 107) and ct...

Full description

Bibliographic Details
Main Authors: Joel Petit, Georgia Carroll, Jie Zhao, Peter Pockney, Rodney J. Scott
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Gastroenterology Insights
Subjects:
colorectal cancer
prognosis
tumour biomarkers
circulating cell-free DNA
circulating tumour-DNA
<i>KRAS</i>
Online Access:https://www.mdpi.com/2036-7422/15/1/8

Internet

https://www.mdpi.com/2036-7422/15/1/8

Similar Items